autologous differentiated t-cells

Cell therapyexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Jun 15, 2017 (NCT03144583)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetImmunity, passive

    Immunity, passive

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • autologous differentiated t-cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03144583Phase 1Jun 15, 2017Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universidad Carlos III Madrid
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Institut d'Investigacions Biomèdiques August Pi i SunyerAcademic/Hospital1112017
Universidad Carlos III MadridAcademic/Hospital1012017
2 organizations
Page 1 / 1